News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Preclinical model for evaluating human TCRs against chimeric syngeneic tumors by Aikaterini Semilietof et al. – JITC
Aikaterini Semilietof/LinkedIn
Dec 26, 2024, 15:46

Preclinical model for evaluating human TCRs against chimeric syngeneic tumors by Aikaterini Semilietof et al. – JITC

A recent paper by Aikaterini Semilietof, Postdoctoral Scholar at the JITC, was mentioned by Journal for ImmunoTherapy of Cancer on X:

“New JITC article.”

“Preclinical model for evaluating human TCRs against chimeric syngeneic tumors”

Authors: Aikaterini Semilietof, Evangelos Stefanidis, Elise Gray-Gaillard, Julien Pujol, Alessia D’Esposito, Patrick Reichenbach, Philippe Guillaume, Vincent Zoete, Melita Irving, Olivier Michielin.

Preclinical model for evaluating human TCRs against chimeric syngeneic tumors by Aikaterini Semilietof et al. - JITC

More posts featuring Journal for ImmunoTherapy of Cancer.

Aikaterini Semilietof Alessia D'Esposito cancer Elise Gray-Gaillard Evangelos Stefanidis JITC Journal for ImmunoTherapy of Cancer Julien Pujol Melita Irving Olivier Michielin OncoDaily Oncology Patrick Reichenbach Philippe Guillaume Vincent Zoete
Special Coverage
Blog
Aug 2, 2025, 10:20
What is the Main Characteristic of Monoclonal Antibodies? - Servier
Blog
Aug 2, 2025, 10:17
Mohamed Kharfan-Dabaja: Great Update on Management of CD30+ non-Hodgkin Lymphomas
Blog
Aug 2, 2025, 10:14
Got Unpublished Research in EGFRm Lung Cancer? - EGFR Resisters Research Summit
Career
Aug 2, 2025, 10:02
Mohamed A Gouda: Starting a New Role as an Assistant Professor of Medical Oncology at MD Anderson Cancer Center
Blog
Aug 2, 2025, 09:59
James Wu: My 1st Ever Lung Cancer Abstract Won an Conquer Cancer, the ASCO Foundation Merit Award
Blog
Aug 2, 2025, 09:35
Tom Powles: 5 Year Efficacy and Biomarker Data for Axitinib/Pembrolizumab in 1st Line Clear Cell RCC
Insight
Aug 2, 2025, 09:30
FASCO 2025: 44 Voices, One Mission
Blog
Aug 2, 2025, 09:28
David Gandara: ISLB Symposium in Tokyo Japan on the Role of Liquid Biopsy in Molecular Testing in a Pan-Cancer Fashion
Blog
Aug 2, 2025, 09:25
Julie Hallet: Defining High-risk Pancreas NETs
Blog
Aug 2, 2025, 09:21
How Federal Policy will Impact the Breast Cancer Community - Susan G. Komen
Blog
Aug 2, 2025, 09:12
Shilpa Gupta: Honored to Co-Chair Our Year 2 Session on "Young Onset Bladder Cancer"
Blog
Aug 2, 2025, 09:05
Estela Rodriguez: Urgent Need to Invest not Only in Lung Cancer Screening but also in Research